$CNS Pharmaceuticals (CNSP.US)$ As of June 30, 2024, the Com...

$CNS Pharmaceuticals (CNSP.US)$ As of June 30, 2024, the Company had cash of approximately $1.5 million. Between June 30, 2024 and August 14, 2024, the Company has raised total gross proceeds of approximately $12.4 million of financing, and has sufficient cash to fund its operations through the first quarter of 2025.